France uses tax to put pressure on hepatitis C drug prices
September 30, 2014 at 07:33 AM EDT
PARIS, Sept 30 (Reuters) - France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.